Muut käyttötavat
Injektio laskimoon (i.v.)
Paller, C. J., Wang, L., Fu, W., Kumar, R., Durham, J. N., Azad, N. S., Laheru, D. A., Browner, I., Kachhap, S. K., Boyapati, K., Odeny, T., Armstrong, D. K., Meyer, C. F., Gaillard, S., Brahmer, J. R., Page, I., Wang, H., & Diaz, L. A., Jr. (2023). Phase I Trial of Intravenous Mistletoe Extract in Advanced Cancer. Cancer Res Commun, 3(2), 338-346. https://doi.org/10.1158/2767-9764.Crc-23-0002
Zuzak TJ, Wasmuth A, Bernitzki S, Schwermer M, Längler A. Safety of high-dose intravenous mistletoe therapy in pediatric cancer patients: A case series. Complement Ther Med. 2018 Oct;40:198-202. Epub 2018 Jan 11. DOI: 10.1016/j.ctim.2018.01.002
Huber R, Schlodder D, Effertz C, Rieger S and Tröger W. Safety of intravenously applied mistletoe extract – results from a phase I dose escalation study in patients with advanced cancer. BMC Complementary and Alternative Medicine (2017) 17:465. DOI 10.1186/s12906-017-1971-1
Kienle G S, Mussler M, Fuchs D and Kiene H. Intravenous Mistletoe Treatment in Integrative Cancer Care: A Qualitative Study Exploring the Procedures, Concepts, and Observations of Expert Doctors. Evid Based Complement Alternat Med, 2016;2016:4628287. DOI: 10.1155/2016/4628287
Schläppi M, Ewald C, Kuehn JJ, Weinert T and Huber R. Fever Therapy With Intravenously Applied Mistletoe Extracts for Cancer Patients: A Retrospective Study. Integrative Cancer Therapies 2016;16(4):479-484.
Steele M L, Axtner J, Happe A, Kroz M, Matthes H and Schad F. Safety of Intravenous Application of Mistletoe (Viscum album L.) Preparations in Oncology: An Observational Study. Evid Based Complement Alternat Med, 2014;2014:236310. DOI:10.1155/2014/236310
Injektio suoraan kasvaimeen tai kasvaimen lähelle
Werthmann P G, Huber R and Kienle G S. Durable clinical remission of a skull metastasis under intralesional Viscum album extract therapy: Case report. Head Neck, 2018;40:E77-E81. DOI: 10.1002/hed.25320
Steele M L, Axtner J, Happe A, Kröz M, Matthes H and Schad F. Use and Safety of Intratumoral Application of European Mistletoe (Viscum album L) Preparations in Oncology. Integrative Cancer Therapies, 2014;14:140-148. DOI: 10.1177/1534735414563977
Werthmann P G, Helling D, Heusser P and Kienle G S. Tumour response following high-dose intratumoural application of Viscum album on a patient with adenoid cystic carcinoma. BMJ Case Rep, 2014;2014. DOI: 10.1136/bcr-2013-203180
Werthmann P G, Strater G, Friesland H and Kienle G S. Durable response of cutaneous squamous cell carcinoma following high-dose perilesional injections of Viscum album extracts--a case report. Phytomedicine, 2013;20:324-327. DOI: 10.1016/j.phymed.2012.11.001
Muuta
Werthmann PG, Hintze A and Kienle GS. Complete remission and long-term survival of a patient with melanoma metastases treated with high-dose fever-inducing Viscum album extract: A case report. Medicine (Baltimore), 2017;96:e8731. DOI: 10.1097/MD.0000000000008731
Orange M, Lace A, Fonseca M P, von Laue B H, Geider S and Kienle GS. Durable Regression of Primary Cutaneous B-Cell Lymphoma Following Fever-inducing Mistletoe Treatment: Two Case Reports. Glob Adv Health Med, 2012;1:18-25. DOI: 10.7453/gahmj.2012.1.1.006
Kienle GS, Grugel R and Kiene H. Safety of higher dosages of Viscum album L. in animals and humans - systematic review of immune changes and safety parameters. BMC Complementary and Alternative Medicine 2011, 11:72.
Orange M, Fonseca MP, Lace A, von Laue HB and Geider S. Durable tumour responses following primary high does induction with mistletoe extracts. Two case reports. European Journal of Integrative Medicine, 2010;2:63-69. DOI: 10.1016/j.eujim.2010.04.001